Frailty and higher PhenoAge are linked with higher cardio-renal-metabolic multimorbidity risk in human cohorts. Higher glucose, insulin-resistance indices, triglycerides, LDL cholesterol and ultra-processed food intake are also linked with higher risk, while physical activity is linked with less progression after a first cardio-renal-metabolic disease. Serum insulin shows no clear link.
45 findings in 21 papers from 2025 to 2026, 15 of them since April 2026
“Moving from LE4-low to LE4-high attenuated the risks of CRMM associated with progressive or persistent obesity trajectories by 26.8-37.8%.”
Serum insulin was not clearly linked with cardio-renal-metabolic multimorbidity in humans (per 1-standard deviation increase in natural log) (HR 1.10 (95% CI 0.91-1.32) per 1-SD increase in natural log).
“Hazard ratios (HRs) of incident CRMM associated with each 1-standard deviation (SD) increase in FPG, 2hPG, insulin (natural log), and HOMA-IR (natural log) were 1.48 (95 % CI: 1.34-1.64)”
Humansper 1-standard deviation increase in natural logmedian follow-up of 15.3 years
C-reactive protein-triglyceride-glucose index is linked with cardio-renal-metabolic multimorbidity in humans (sustained or progressive obesity trajectories) (approximately 42-54% of the associations).
“CTI mediated approximately 42-54% of the associations between sustained or progressive obesity trajectories and CRMM comorbidity outcomes.”
Humanssustained or progressive obesity trajectories
Kidney function is linked with cardio-renal-metabolic multimorbidity in humans.
“Mediation analyses indicated that systemic inflammation, organ function, and especially kidney function partially mediated the observed associations.”
Humanspartial mediation of associations between insulin resistance-related indices and CRM multimorbidity
MetaboHealth score is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (fully adjusted Cox models) (HR 1.503 (95% CI 1.469-1.538, p < 0.001)).
“1.503 (95% CI 1.469-1.538, p < 0.001), respectively.”
Alternative healthy eating INDEX-2010 is associated with cardio-renal-metabolic multimorbidity in humans (Initially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysis) (51% lower risk; HR 0.49, 95% CI 0.35–0.70; P for trend = 0.007).
“Greater adherence to the DASH and AHEI-2010 diet quality indices may be inversely associated with risk of CRMM.”
HumansInitially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysisHighest versus lowest tertile of AHEI-2010 scoreMedian follow-up of 11.6 yearsn = 2,539
Dash diet is associated with cardio-renal-metabolic multimorbidity in humans (Initially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysis) (38% lower risk; HR 0.62, 95% CI 0.42–0.90; P for trend = 0.038).
“Greater adherence to the DASH and AHEI-2010 diet quality indices may be inversely associated with risk of CRMM.”
HumansInitially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysisHighest versus lowest tertile of DASH scoreMedian follow-up of 11.6 yearsn = 2,539
Sleep duration is associated with cardio-renal-metabolic multimorbidity in humans (Postmenopausal women; compared with the normal-stable sleep duration trajectory) (OR 2.30, 95% CI 1.35–3.91).
“Compared with normal-stable group, those in normal-fluctuating decline and short-rapid decline groups had an increased risk of CRMM”
HumansPostmenopausal women; compared with the normal-stable sleep duration trajectorynormal-fluctuating declinemedian follow-up of 2 yearsfemalesn = 2,859
Metabolic vulnerability index is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (fully adjusted Cox models) (HR 1.213 (95% CI 1.186-1.241, p < 0.001)).
“each 1-SD increment in MVX and the MetaboHealth score was associated with a higher risk of incident CRM multimorbidity, with HRs of 1.213 (95% CI 1.186-1.241, p < 0.001)”
Compared with the lowest risk category, the highest was associated with hazard ratios of 2.80, 1.84 and 1.71 for developing one, two and three conditions.Compared with the lowest risk category, the highest was associated with hazard ratios of 2.80, 1.84 and 1.71 for developing one, two and three conditions.
Who was studied262,464 UK Biobank participants without cardio-renal-metabolic disease
What changedDeveloping a second cardiovascular, kidney, or metabolic disease was more likely with highest versus lowest biomarker burden (hazard ratio 1.84)
The catchSelecting and evaluating biomarkers in the same cohort risks overstating their predictive associations
In the UK Biobank, participants with high AIP and low eGDR had a hazard ratio of 5.24 for multimorbidity compared with the low-AIP and high-eGDR group.In the UK Biobank, participants with high AIP and low eGDR had a hazard ratio of 5.24 for multimorbidity compared with the low-AIP and high-eGDR group.
Preprint: cohort study of 394,483 peopleBiomarkers